Progenity, Inc. Stock News

5 Reddit penny stocks to watch right now. The post 5 Top Penny Stocks To Buy Now According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Reddit penny stocks to watch right now. The post 5 Top Penny Stocks To Buy Now According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week? 4 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

Are these penny stocks on your watchlist for next week? The post Can These Penny Stocks Climb This Week?

Penny stocks to watch as retail traders take aim at 2022. The post 5 Hot Meme Stocks To Buy For Pennies Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Progenity Inc (PROG) shares closed today 10.7% lower than it did at the end of yesterday. The stock is currently down 27.8% year-to-date, down 72.1% over the past 12 months, and down 88.5% over the past five years. Today, the Dow Jones Industrial Average fell 1.5%, and the S&P 500 fell 1.8%. Trading Activity Shares traded as high as $1.97 and as low as $1.50 this week.Shares closed 80.8% below its 52-week high and 129.8% above its 52-week low.Trading volume this week was 9.0% higher than the 10-day average and 3.2% lower than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 293.3% The company's stock price performance over the past 12 months lags the peer average by 632.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Progenity, Inc. ( PROG , Financial) is a biotech stock with an innovative pipeline. The company has been deriving its revenues from molecular laboratory tests, mainly from the sale of its Innatal, Pre

Dr. Bram Verstockt to present patient data establishing correlation between drug levels in colon and clinical outcomes Dr. Bram Verstockt to present patient data establishing correlation between drug

Progenity spent 2021 reinventing itself, dumping its testing laboratory, hiring a new CEO, and refocusing on its patent portfolio. PROG stock hopes its patent portfolio can result in new tests and tre

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today ann

Are these penny stocks on your January watchlist? The post Are These Penny Stocks on Your January 2022 List? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are these penny stocks on your January watchlist? The post Are These Penny Stocks on Your January 2022 List?

There's a mismatch as Progenity's patent portfolio keeps growing, yet PROG stock has declined. A turnaround could be in store very soon.

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today ann

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today annou